Concepedia

Yuqin Song

YS

25

Publications

609

Citations

16

H-Index

2010

Active since

Affiliations

Peking University Cancer Hospital(Current)

Peking University

Chinese Academy of Medical Sciences & Peking Union Medical College

Tianjin Medical University Cancer Institute and Hospital

Fudan University Shanghai Cancer Center

Yuqin Song is an author at Peking University Cancer Hospital specializing in medicine, oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2025

25

Publications

25

Human Papillomavirus Infection and Esophageal Squamous Cell Carcinoma: A Case–Control Study

Fangcen Guo, Ying Liu, Xueqian Wang et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 77 citations · Full text

A phase I study of the oral mTOR inhibitor ridaforolimus (RIDA) in combination with the IGF-1R antibody dalotozumab (DALO) in patients (pts) with advanced solid tumors.

Serena Di Cosimo, J. C. Bendell, Andrés Cervantes et al. · Journal of Clinical Oncology · 2010 · 67 citations

, , +21

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Yuqin Song, Hervé Tilly, Shinya Rai et al. · Blood · 2023 · 42 citations · Full text

, , +21

Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUV<sub>max-liver</sub>-based interpretation for predicting the outcome in diffuse large B-cell lymphoma

Fan Yang, Yuewei Zhang, Zhi Yang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 40 citations

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Yuqin Song, Keshu Zhou, Dehui Zou et al. · Blood · 2018 · 38 citations

Rows per page

1–5 of 25